Fig 1: Siponimod modulates microglial cytokine expression and secretion in an inflammatory milieu. (A,C,E,G) quantitative RT-PCR analysis of Tnf (A), Ifnb (C), Il1b (E) and Il10 (G) gene expression after stimulation for 1 day with +/− 50 µM siponimod +/− LPS. (B,D,F,H) Quantification of TNF-α (B), IFNβ (D), IL-1β (F) and IL-10 (H) protein concentration in the cell culture medium of microglial cells stimulated for 3 days with +/− 50 µM siponimod +/− LPS using respective quantitative sandwich ELISA assays. Grey-dotted lines indicate the lowest standard of the ELISA kit: TNFα = 82.3 pg/mL, IFNβ = 15.63 pg/mL, IL-1β = 68.59 pg/mL and IL-10 = 8.23 pg/mL. Data are presented as mean values ± SEM. Grey dots represent individual data points. Significance of gene expression analysis as well as ELISA was assessed by 1-way analysis of variance (ANOVA) followed by Tukey’s post hoc test using Graph-Pad Prism 8.4.3 (GraphPad Software, San Diego, CA, USA). The experimental groups were considered significantly different at ** p < 0.01, *** p < 0.001.
Fig 2: In vivo validation of CA@PDX HMs-mediated metabolic and immune microenvironment remodeling via the AMPK/PPARγ axis in OA tissues. (A) Experimental workflow (left) and schematic illustration (right) of CA@PDX HMs regulating the AMPK/PPARγ axis; (B) Western blot analysis of p-AMPK and PPARγ protein expression in cartilage; (C) RT-qPCR analysis of Prkaa1, Pparg, Il10, Nos2, and Mmp13 mRNA levels; (D) IHC staining of p-AMPK and PPARγ distribution in cartilage. Scale bar: 25 μm; (E-F) IHC analysis of ARG1 and IL-10 expression in synovial tissue. Scale bar: 25 μm. Each group included six rats. ****p < 0.0001
Supplier Page from Abcam for Rat IL-10 ELISA Kit